No Data
No Data
Wellnex Life to Launch Medicinal Cannabis Product Range; Shares Fall 3%
Wellnex Life (ASX:WNX) is set to launch a medicinal cannabis range of products, named Wellnex Life, by July 1, according to a Wednesday filing with the Australian bourse. The products will be initiall
Wellnex Life Gets Set to Bring Medicinal Cannabis to the Australian Market
Consumer healthcare business Wellnex Life Ltd (ASX:WNX) is set to introduce a new medicinal cannabis brand – Wellness Life – to the Australian market, where it will be sold at Chemist Warehouse stores and also be prescribed through teleheath provider InstantConsult.
Wellnex Life Records AU$2 Million in Orders for April; Shares Jump 17%
Wellnex Life (ASX:WNX) posted AU$2 million of orders in April and a record of about AU$350,000 in operating profit, according to a Thursday Australian bourse filing. Gross margins for the January to A
Wellnex Life Expands Wakey Wakey Range With Two New Products
Wellnex Life (ASX:WNX) launched two new products under the Wakey Wakey brand, expanding the range to eight product lines, and increasing the company's presence in the health and pharmaceutical market,
Wellnex Life's Loss Widens in H1 FY24
Wellnex Life's (ASX:WNX) net loss attributable to shareholders widened by 131.5% to AU$9.8 million in the half-year ended Dec. 31, 2023, from AU$4.2 million a year ago, according to a Thursday filing
Wellnex Life's Paracetamol Soft Gel Liquid Analgesic Secures UK Regulatory Approval; Shares Climb 4%
Wellnex Life's (ASX:WNX) paracetamol soft gel liquid pain reliever, which was registered with the Therapeutic Goods Administration (TGA), obtained regulatory approval in the UK, allowing its sale in t
No Data